← Back to Blog

Fentanyl Prosecutions and the Critical Role of Medical Toxicologists

The Expert Witness at the Center of the Case

In a federal fentanyl distribution-resulting-in-death prosecution, the most important witness is often not a law enforcement agent, a cooperating informant, or even the defendant. It's the medical toxicologist.

As the Department of Justice has escalated its prosecution of fentanyl trafficking and distribution — making it a stated enforcement priority across multiple administrations — the demand for qualified medical toxicologists and forensic pathologists has intensified on both sides of these cases.

Why Causation Is Everything

The charge that drives the most significant sentences in fentanyl cases is distribution resulting in death under 21 U.S.C. § 841(b)(1)(C), which carries a mandatory minimum of 20 years. To secure a conviction, the prosecution must prove that the fentanyl distributed by the defendant was the *but-for cause* of the victim's death.

This sounds straightforward. It isn't.

The Polydrug Reality

The vast majority of fentanyl decedents have multiple substances in their systems. CDC data from 2023 shows that nearly 47% of opioid overdose deaths also involved stimulants. Alcohol, benzodiazepines, methamphetamine, cocaine, xylazine, and other opioids commonly appear alongside fentanyl in postmortem toxicology.

For the prosecution's medical toxicologist, the task is to testify credibly that fentanyl — not the cocktail of other substances — was the but-for cause of death. For the defense's medical toxicologist, the task is to demonstrate that the polysubstance picture makes but-for attribution unreliable.

Postmortem redistribution — the phenomenon where drug concentrations shift in the body after death, potentially inflating or deflating apparent levels — adds further complexity. So does the question of tolerance: a chronic opioid user may survive blood concentrations that would kill an opioid-naive individual.

The Forensic Pathologist's Role

The forensic pathologist provides the other essential piece of expert testimony: the cause-of-death determination based on the autopsy. Defense attorneys frequently challenge whether the autopsy findings actually support fentanyl as the cause of death, particularly when the decedent had pre-existing conditions or when the toxicology report shows multiple potentially lethal substances.

In a November 2024 case in the Middle District of Pennsylvania, the prosecution called 19 witnesses, including a forensic pathologist, a forensic toxicologist, two forensic chemists, a forensic cell phone examiner, a DNA expert, and a drug trafficking expert. That lineup illustrates the breadth of expert testimony these cases require.

A Small Field, Enormous Demand

Board-certified medical toxicologists number approximately 500 in the United States. Not all are willing to serve as expert witnesses, and those who are willing are being retained rapidly across hundreds of federal and state cases.

This is the dynamic Peter George described in his 2023 post on this blog — a limited pool of qualified experts, a vast number of cases, and a premium on speed and accuracy. Whether you are a federal prosecutor, an AUSA, or a defense attorney retained to challenge the government's causation theory, the quality of your toxicology and pathology experts will likely be the most important variable in the outcome.

State Prosecutions Add Volume

Many states have enacted or strengthened drug-induced homicide statutes. These state-level prosecutions mirror the federal expert witness requirements but with varying causation standards that directly affect the scope and content of expert testimony. Some states require but-for causation; others use a contributing-cause standard that is more prosecution-friendly. Understanding the applicable standard in your jurisdiction is essential to selecting the right expert.

The Vident Advantage

Vident Partners has extensive experience identifying medical toxicologists, forensic pathologists, forensic toxicologists, and pharmacologists for both prosecution and defense in fentanyl cases. [Contact us](https://www.videntpartners.com/#contact) for a consultation.

References

1. CDC NCHS, "U.S. Overdose Deaths Decrease Almost 27% in 2024" (May 2025). 2. CDC, "About Overdose Prevention" (Jan. 2026) — 69% of 2023 overdose deaths involved synthetic opioids. 3. DEA, 20 fentanyl-distribution-resulting-in-death cases in Central District of California (May 2025). 4. DOJ/USAO-SDCA, San Diego fentanyl conviction — Board-certified medical toxicologist testimony on but-for causation. 5. DOJ/USAO-HI, Hawaii fentanyl conviction — Medical toxicologist testimony on polydrug but-for causation (Dec. 2024). 6. DOJ/USAO-MDPA, Pennsylvania fentanyl conviction — 19 witnesses including forensic pathologist and forensic toxicologist (Nov. 2024). 7. NAAG, "Prosecuting Drug Overdose Cases: A Paradigm Shift" — On the critical importance of consulting toxicologists before initiating prosecution. 8. Peter George, "Looking for a unicorn?", Vident Partners Blog (Oct. 10, 2023).

Optimal Outcomes

Optimal Outcomes

Are you a lawyer or law firm seeking expert witnesses or testifying experts? Let us know and we'll be in touch!